Propranolol, a beta-blocker in most cases prescribed to address irregular heart rates and other conditions, has main anti-most cancers properties, insist researchers in a brand fresh clinical glimpse printed in ecancermedicalscience.

The Repurposing Medication in Oncology (ReDO) project, a world collaboration between the Anticancer Fund, Belgium, and US based entirely GlobalCures, says that existing and broadly-used non-most cancers medication might well also signify a rather untapped source of fresh therapies for most cancers.

Historically, pharmaceutical companies devote minute time to “repurposing” existing medication. The ReDO project hopes to interchange that, elevating awareness by publishing a chain of articles in ecancer to part proof for the expend of these therapies in most cancers medication.

Hits: 3